GlassScriptPhysician profile
Shawn D Blick
NPI 1912970609
$335,904.56
in general payments reported to CMS, 2019-2025
55 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $33K · 2021: $20K · 2022: $66K · 2023: $46K · 2024: $62K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $115K · Food and Beverage: $7,493 · Travel and Lodging: $7,103 · Consulting Fee: $2,050 · Grant: $3.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $115,480.00 |
| Food and Beverage | $7,492.96 |
| Travel and Lodging | $7,103.13 |
| Consulting Fee | $2,050.00 |
| Grant | $3.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $326,199.52 | 2019-2025 | Advance Xp, Tactra, Ams 700 |
| Axonics, INC. | $1,606.38 | 2021-2024 | Bulkamid, Axonics |
| Neotract INC. | $1,218.00 | 2019 | |
| Coloplast Corp | $811.90 | 2019-2025 | Titan |
| Urogen Pharma, INC. | $591.76 | 2021-2025 | Jelmyto |
| Abbvie INC. | $487.48 | 2019-2025 | |
| Astellas Pharma US INC | $424.76 | 2019-2023 | Myrbetriq |
| Antares Pharma, INC. | $391.66 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Innovation Technologies INC | $345.87 | 2021-2024 | Irrisept |
| Procept Biorobotics Corporation | $328.49 | 2022-2025 | Aquabeam System |
| Endo Pharmaceuticals INC. | $325.54 | 2019-2023 | Aveed, Xiaflex |
| Teleflex LLC | $278.64 | 2021-2025 | Barrigel, Urolift |
| Blue Earth Diagnostics | $249.76 | 2019-2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $223.35 | 2021-2024 | Prolaris |
| Janssen Biotech, INC. | $196.38 | 2019-2025 | Erleada |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Blick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.